Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

Neal J. Riley is a digital producer for CBS Boston. He has been with WBZ-TV since 2014. His work has appeared in The Boston Globe and The San Francisco Chronicle. Neal is a graduate of Boston ...

Over the last several years, Apple has dramatically improved how it handles lithium-ion battery charging in iPhones, iPads, Macs, and Apple Watches. Across multiple system releases, the company moved ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

People everywhere are using AI to get creative, spend more time with loved ones and ditch mundane tasks — all things they wouldn’t have even imagined a year ago, before generative AI became widely ...

The phrase “cash is king” may not have the same ring as it used to, now that more than 40% of Americans, per the Pew Research Center, regularly go a week or more without paying for anything using ...

Learn how to do type-in, image and voice search, plus how to use Google Search for different content types and formats. The web can be an overwhelming source of information, disinformation, news, ...

Some of the Capital One offers mentioned below are not currently available. Terms apply to American Express benefits and offers. Visit americanexpress.com to learn more. There are a lot of perks that ...

If a business wants to offset processing fees, you could have to pay a surcharge for using a credit card. However, if you want to avoid this fee, pay with your debit card, cash or check. Paying a ...

Troy Adkins has 15+ years of residential property investment analysis experience and over a decade of institutional investment consulting experience. Vikki Velasquez is a researcher and writer who has ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...